Takanori Matsui

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Toru Kono, Taishi Hata, Satoshi Morita et al. · Cancer Chemotherapy and Pharmacology · 2013 · 106 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).

Yasuhiro Kodera, Seiji Ito, Yoshinari Mochizuki et al. · PubMed · 2007 · 100 citations

Medicine, Oncology, Pharmacology +17

Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.

Koji Oba, Michiya Kobayashi, Takanori Matsui et al. · PubMed · 2009 · 97 citations

Medicine, Oncology, Pharmacology +10

Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study

Yasuhiro Kodera, Seiji Ito, Yoshinari Mochizuki et al. · Gastric Cancer · 2012 · 96 citations · Full text

Medicine, Gynecology, Pathology +5